{"id":9507,"date":"2026-01-05T23:03:04","date_gmt":"2026-01-05T23:03:04","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/01\/05\/biotech-news-insilico-cancer-drug-deal\/"},"modified":"2026-01-05T23:03:04","modified_gmt":"2026-01-05T23:03:04","slug":"biotech-news-insilico-cancer-drug-deal","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/01\/05\/biotech-news-insilico-cancer-drug-deal\/","title":{"rendered":"STAT+: Insilico inks cancer drug deal with Servier after IPO"},"content":{"rendered":"<p>    STAT+: Insilico inks cancer drug deal with Servier after IPO<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Welcome back and happy new year!<\/p>\n<p>We have plenty of fresh coverage to start the week. We can also report that our upcoming STAT@JPM event \u2014 featuring Richard Pazdur and Yvonne Greenstreet, among others \u2014 is sold out. There\u2019s a <a href=\"https:\/\/www.statnews.com\/event\/stat-at-jpm-live-event-2026\/#waitlist\" rel=\"noopener\">waitlist<\/a> if you\u2019d like to sign up.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2026\/01\/05\/biotech-news-insilico-cancer-drug-deal\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Meghana Keshavan<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2026\/01\/05\/biotech-news-insilico-cancer-drug-deal\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Insilico inks cancer drug deal with Servier after IPO Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Welcome back and happy new year! We have plenty of fresh coverage to start the week. We can also report that our upcoming STAT@JPM [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-9507","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/9507"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=9507"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/9507\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=9507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=9507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=9507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}